Related Experiment Video
Updated: May 25, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients
Katsuhiko Sarazawa1, Akira Nakano, Hiroyasu Uzui
1First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, Japan.
Insights
Acute hyperglycemia (AHG) in ST-segment elevation myocardial infarction (STEMI) patients impairs myocardial microcirculation, leading to worse outcomes. This study found AHG is linked to reduced myocardial flow reserve and poorer heart function recovery.
Area of Science:
- Cardiology
- Internal Medicine
- Medical Imaging
Background:
- Acute hyperglycemia (AHG) is linked to adverse outcomes in ST-segment elevation myocardial infarction (STEMI) patients.
- The mechanisms by which AHG affects myocardial microcirculation in STEMI remain unclear.
Purpose of the Study:
- To investigate the impact of AHG on myocardial microcirculation in STEMI patients undergoing reperfusion therapy.
Main Methods:
- Thirty-four STEMI patients were categorized into groups with (Group H) or without (Group L) AHG.
- Myocardial blood flow (MBF) and myocardial flow reserve (MFR) were assessed using ¹³N-ammonia positron emission tomography.
- Wall motion abnormality scores (WMASs) and end-diastolic volume indices (EDVI) were evaluated at 1 and 6 months post-event.
Main Results:
- Group H exhibited significantly lower MFR compared to Group L (P = .001).
- WMAS was higher in Group H at both 1 and 6 months (P = .011 and P = .015, respectively).
- Multivariate analysis identified AHG as an independent predictor of low MFR.
Conclusions:
- AHG negatively impacts myocardial microcirculation in STEMI patients.
- Impaired microcirculation due to AHG contributes to reduced functional recovery and adverse cardiac remodeling.
- These findings highlight the importance of managing hyperglycemia in STEMI patients.
Background:
Although acute hyperglycemia (AHG) is associated with poor outcomes in ST-segment elevation myocardial infarction (STEMI) patients, underlying mechanisms have not been fully elucidated. We investigated the influence of AHG on myocardial microcirculation in reperfused STEMI patients.
Methods And Results:
Thirty-four STEMI patients were divided into 2 groups according to the presence (Group H, n 5 11) or the absence (Group L, n 5 23) of AHG. Myocardial blood flow (MBF) and myocardial flow reserve (MFR) in the infarct-related area were compared between 2 groups, using ¹³N-ammonia positron emission tomography. Wall motion abnormality scores (WMASs) and end-diastolic volume indices (EDVI) were also assessed at 1 and 6 months after the onset. Although resting MBF was similar, MFR was lower in Group H than in Group L (1.69 ± 0.37 vs 2.39 ± 0.56, P = .001). WMAS was greater in Group H than in Group L at both 1 month (7.4 ± 3.7 vs 3.7 ± 3.0, P = .011) and 6 months (7.3 ± 3.9 vs 3.1 ± 3.4, P = .015). EDVI tended to be greater in Group H than in Group L at 6 months (103.8 ± 42.9 vs 73.9 ± 16.0 mL/m2, P = .071). Multivariate analysis showed AHG to be independently associated with low MFR.
Conclusions:
In STEMI patients, AHG impaired myocardial microcirculation, leading to poor functional recovery and remodeling despite successful reperfusion.
Related Concept Videos
Hyperglycemia
Complications of Diabetes Mellitus
Diabetic Nephropathy
Acute Coronary Syndrome I: Introduction
Diabetic Retinopathy
Acute Pancreatitis II: Clinical Manifestations and Management